Author Archives: Sunlight Xiang

I-Mab CD73 Antibody Junshi PD-1 mAb

I-Mab to Test its CD73 Antibody in Combination with Junshi’s PD-1 mAb

Life Science

AstraZeneca Wuxi International Life Science Innovation Campus

AstraZeneca, Wuxi City Partner to Open New China Life Science Park

Life Science

Laviana B+ financing CDMO

Laviana Raises $14 Million for CDMO Operations in China

Life Science

Eli Lilly LOXO-292（selpercatinib） RET fusion-positive non-small cell lung cancer (NSCLC)

Lilly’s $8 Billion Bet Pays Off With Dazzling Results in Lung Cancer Trial

Life Science

PAG Hisun BioRay biologics

PAG Pays $540 Million for Majority Stake in Hisun BioRay, a Biologics Company

Life Science

Sumitomo Dainippon Roivant

Sumitomo Dainippon Buys 5 Roivant Companies for $3 Billion with Option to Buy 6 More

Life Science

Novartis IFM Due immunotherapies

Novartis Inks $840 Million Collaboration and Option Deal with IFM Due

Life Science

Immunotech Hong Kong IPO EAL

Beijing’s Immunotech Plans to Raise up to $200 Million in Hong Kong IPO

Life Science

AstraZeneca Tagrisso (osimertinib) China

AstraZeneca’s Tagrisso Approved in China as First-Line Lung Cancer Treatment

Life Science

Quan Capital Zai Lab second fund

Quan Capital Closes Second Healthcare Fund at $275 Million

Life Science

Meituan quarterly profit

Meituan Surges to Highest Since IPO After Surprise Profit

Others

China unapproved drug imports

China loosens curbs on small, unapproved drug imports

Life Science

AIVITA Biomedical stem cell immunotherapy

Brain Cancer Patients Display Decreasing Tumor Biomarkers After Treatment with Novel Immunotherapy in AIVITA Biomedical’s Phase 2 Clinical Trial

Life Science

Options trading basic strategies Greeks

Options Insights: Trading your First Option

Life Science

options trading

Beginner’s guide to options trading

Financial Service

1
2